Jenny Seugkin Tang

Title: Jenny Seugkin Tang: Innovator in Cytokine Production Inhibitors

Introduction

Jenny Seugkin Tang is a notable inventor based in Slough, GB. She has made significant contributions to the field of biotechnology, particularly in the development of compounds that inhibit cytokine production and tyrosine kinase activity. Her work is crucial in addressing immunoinflammatory and cancerous conditions.

Latest Patents

Jenny holds a patent for a compound that has the potential to inhibit cytokine production and tyrosine kinase. The patent describes a compound of formula (I), wherein αX is =O, =N—OR, βNHR, or βOH, with R being H or C-C alkyl. The compound's structure allows for various orientations and substitutions, making it versatile in its application. The patent also outlines processes for producing these compounds from fungal strains and synthetic analogues, emphasizing their therapeutic uses.

Career Highlights

Jenny is currently associated with Xenova Limited, where she continues her research and development efforts. Her innovative work has positioned her as a key figure in her field, contributing to advancements in medical treatments.

Collaborations

Jenny has collaborated with notable colleagues, including Sangeeta Bahl and Roya Mansour Sadeghi Guilani. These partnerships have enhanced her research and broadened the impact of her inventions.

Conclusion

Jenny Seugkin Tang is a pioneering inventor whose work in cytokine production inhibitors is paving the way for new treatments in immunoinflammatory and cancerous conditions. Her contributions to biotechnology are invaluable and continue to inspire future innovations.